An October 2024 review from the American Heart Association cited two recent studies showing that less than half of the weight lost from GLP-1 medications came from fat, with a substantial portion coming from muscle mass
Side Effects & Safety AOD-9604 has a genuinely clean safety profile based on both clinical studies and community use: Injection site reactions: Mild redness or bruising, common and temporary Headache: Reported by a minority of users in the first week, typically self-resolving Fatigue: Occasional, especially at higher doses usually resolves No significant hormonal disruption: Unlike full HGH, no thyroid, insulin, or IGF-1 concerns at standard doses AOD-9604 received GRAS (Generally Recognized As Safe) status from the FDA for use as a food ingredient during its development phase an unusual distinction that reflects its clean clinical safety data
The detection and quantification of acylcarnitine compounds can be challenging since many species occur as isomers and are found at very low concentrations in biological samples
Dihydroxyacetone induces G2/M arrest and apoptotic cell death in A375P melanoma cells
Potential Reactions: Some patients may experience mild or temporary effects such as injection site irritation, fatigue, nausea, headaches, or other unexpected symptoms
Here is an example of one study done in adolescents